Psilocybin: a revolution in psychedelic medicines in the US?
BMJ – October 06, 2022
Source: OpenAlex
Summary
Psilocybin, a potent hallucinogen, is emerging as a potential game-changer in Psychiatry and Medicine. With two US states already approving its medicinal use, this most carefully studied psychedelic drug is sparking intense interest. Psychology and Drug Studies are actively investigating its profound efficacy in treating Depression and other psychiatric ailments. The question now is whether psilocybin will truly revolutionize mental healthcare, offering new hope for millions.
Abstract
As a flurry of US states approve psilocybin for medicinal use, Joanne Silberner asks whether the most carefully studied of psychedelic drugs will revolutionise treatment of depression and other psychiatric ailments